|
71
|
275
|
2x4pA |
Crystal structure of mhc class i hla-a2.1 bound to a photocleavable peptide |
|
72
|
275
|
2x4sA |
Crystal structure of mhc class i hla-a2.1 bound to a peptide representing the epitope of the h5n1 (avian flu) nucleoprotein |
|
77
|
275
|
2x4uA |
Crystal structure of mhc class i hla-a2.1 bound to hiv-1 peptide rt468-476 |
|
71
|
275
|
2x4tA |
Crystal structure of mhc class i hla-a2.1 bound to a peiodate- cleavable peptide |
|
73
|
275
|
2x4qA |
Crystal structure of mhc class i hla-a2.1 bound to a photocleavable peptide |
|
60
|
176
|
2wy3A |
Structure of the hcmv ul16-micb complex elucidates select binding of a viral immunoevasin to diverse nkg2d ligands |
|
70
|
276
|
2vlrA |
The structural dynamics and energetics of an immunodominant t-cell receptor are programmed by its vbeta domain |
|
78
|
275
|
2vllA |
The structural dynamics and energetics of an immunodominant t-cell receptor are programmed by its vbeta domain |
|
80
|
274
|
2vabA |
Mhc class i h-2kb heavy chain complexed with beta-2 microglobulin and sendai virus nucleoprotein |
|
68
|
276
|
2vlkA |
The structural dynamics and energetics of an immunodominant t-cell receptor are programmed by its vbeta domain |
|
71
|
276
|
2vljA |
The structural dynamics and energetics of an immunodominant t-cell receptor are programmed by its vbeta domain |
|
65
|
276
|
2ve6A |
Crystal structure of a murine mhc class i h2-db molecule in complex with a photocleavable peptide |
|
77
|
275
|
2v2xA |
T cell cross-reactivity and conformational changes during tcr engagement. |
|
80
|
274
|
2vaaA |
Mhc class i h-2kb heavy chain complexed with beta-2 microglobulin and vesicular stomatitis virus nucleoprotein |
|
74
|
275
|
2v2wA |
T cell cross-reactivity and conformational changes during tcr engagement |
|
80
|
275
|
2uweA |
Large cdr3a loop alteration as a function of mhc mutation |
|
75
|
275
|
2rfxA |
Crystal structure of hla-b*5701, presenting the self peptide, lsspvtksf |
|
70
|
273
|
2q7yA |
Structure of the endogenous inkt cell ligand igb3 bound to mcd1d |
|
72
|
276
|
2pyeA |
Crystal structures of high affinity human t-cell receptors bound to pmhc revealnative diagonal binding geometry tcr clone c5c1 complexed with mhc |
|
62
|
275
|
2po6A |
Crystal structure of cd1d-lipid-antigen complexed with beta-2-microglobulin, nkt15 alpha-chain and nkt15 beta-chain |
|
78
|
276
|
2p5wA |
Crystal structures of high affinity human t-cell receptors bound to pmhc reveal native diagonal binding geometry |
|
74
|
276
|
2p5eA |
Crystal structures of high affinity human t-cell receptors bound to pmhc reveal native diagonal binding geometry |
|
68
|
276
|
2o5nA |
Crystal structure of a viral glycoprotein |
|
50
|
175
|
2oi9A |
Structure of the 2c/ld/ql9 allogeneic complex |
|
65
|
276
|
2ol3H |
Crystal structure of bm3.3 scfv tcr in complex with pbm8-h-2kbm8 mhc class i molecule |
|
64
|
261
|
2nykA |
Crystal structure of m157 from mouse cytomegalovirus |
|
72
|
276
|
2nx5A |
Crystal structure of els4 tcr bound to hla-b*3501 presenting ebv peptide eplpqgqltay at 1.7a |
|
55
|
270
|
2mhaA |
Crystal structure of the major histocompatibility complex class i h-2kb molecule containing a single viral peptide: implications for peptide binding and t-cell receptor recognition |
|
73
|
275
|
2jccA |
Ah3 recognition of mutant hla-a2 w167a |
|
66
|
275
|
2j8uA |
Large cdr3a loop alteration as a function of mhc mutation. |
|
58
|
178
|
2ia1A |
Crystal structure of protein bh3703 from bacillus halodurans, pfam duf600 |
|
81
|
274
|
2hn7A |
Hla-a*1101 in complex with hbv peptide homologue |
|
79
|
274
|
2hjlA |
Crystal structure of hla-b5703 and hiv-1 peptide |
|
81
|
275
|
2guoA |
Human class i mhc hla-a2 in complex with the native nonameric melan-a/mart-1(27-35) peptide |
|
73
|
270
|
2hlaA |
Specificity pockets for the side chains of peptide antigens in hla-aw68 |
|
76
|
276
|
2h6pA |
Crystal structure of hla-b*3501 presenting the human cytochrome p450 derived peptide, kpivvlhgy |
|
77
|
274
|
2hjkA |
Crystal structure of hla-b5703 and hiv-1 peptide |
|
82
|
275
|
2gtzA |
Human class i mhc hla-a2 in complex with the nonameric melan-a/mart-1(27-35) peptide having a28l substitution |
|
78
|
283
|
2h26A |
Human cd1b in complex with endogenous phosphatidylcholine and spacer |
|
79
|
275
|
2gtwA |
Human class i mhc hla-a2 in complex with the nonameric melan-a/mart-1(27-35) peptide having a27l substitution |
|
78
|
275
|
2gt9A |
Human class i mhc hla-a2 in complex with the decameric melan-a/mart-1(26-35) peptide |
|
76
|
275
|
2gj6A |
The complex between tcr a6 and human class i mhc hla-a2 with the modified htlv-1 tax (y5k-4-[3-indolyl]-butyric acid) peptide |
|
77
|
275
|
2gitA |
Human class i mhc hla-a2 in complex with the modified htlv-1 tax (y5k-4-[3-indolyl]-butyric acid) peptide |
|
79
|
273
|
2gazA |
Mycobacterial lipoglycan presentation by cd1d |
|
74
|
276
|
2fz3A |
The role of t cell receptor alpha genes in directing human mhc restriction |
|
74
|
275
|
2fwoA |
Mhc class i h-2kd heavy chain in complex with beta-2microglobulin and peptide derived from influenza nucleoprotein |
|
72
|
274
|
2fo4A |
Enhanced mhc class i binding and immune responses through anchor modification of the non-canonical tumor associated muc1-8 peptide |
|
74
|
276
|
2fyyA |
The role of t cell receptor alpha genes in directing human mhc restriction |
|
78
|
272
|
2fikA |
Structure of a microbial glycosphingolipid bound to mouse cd1d |
|
80
|
275
|
2f53A |
Directed evolution of human t-cell receptor cdr2 residues by phage display dramatically enhances affinity for cognate peptide-mhc without apparent cross-reactivity |
